Detalhe da pesquisa
1.
Modification of the cyclopropyl moiety of abacavir provides insight into the structure activity relationship between HLA-B*57:01 binding and T-cell activation.
Allergy
; 75(3): 636-647, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31549414
2.
Safety pharmacology--current and emerging concepts.
Toxicol Appl Pharmacol
; 273(2): 229-41, 2013 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23732082
3.
Characterization of In vitro inhibitory effects of consensus short interference RNAs against non-structural 5B gene of hepatitis C virus 1a genotype.
Indian J Med Microbiol
; 36(4): 494-503, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30880695
4.
Towards depersonalized abacavir therapy: chemical modification eliminates HLA-B*57 : 01-restricted CD8+ T-cell activation.
AIDS
; 29(18): 2385-95, 2015 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26372480
5.
Immunogenicity to biologics: mechanisms, prediction and reduction.
Arch Immunol Ther Exp (Warsz)
; 60(5): 331-44, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22930363